These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model. Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519 [TBL] [Abstract][Full Text] [Related]
35. [Mutation-specific treatments for Duchenne muscular dystrophy]. Matsuo M; Takeshima Y Brain Nerve; 2009 Aug; 61(8):915-22. PubMed ID: 19697880 [TBL] [Abstract][Full Text] [Related]
36. Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies. Mareedu S; Million ED; Duan D; Babu GJ Front Physiol; 2021; 12():647010. PubMed ID: 33897454 [TBL] [Abstract][Full Text] [Related]
37. Genetic correction strategies for Duchenne Muscular Dystrophy and their impact on the heart. Johnston JR; McNally EM Prog Pediatr Cardiol; 2021 Dec; 63():. PubMed ID: 34898968 [TBL] [Abstract][Full Text] [Related]
38. Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy. Naidoo M; Anthony K Mol Neurobiol; 2020 Mar; 57(3):1748-1767. PubMed ID: 31836945 [TBL] [Abstract][Full Text] [Related]